Efficacy and renal outcomes of SGLT2 inhibitors in patients with type 2 diabetes and chronic kidney disease

Michael S. Kelly, Jelena Lewis, Ashley M. Huntsberry, Lauren Dea, Ivan Portillo
  • Postgraduate Medicine, November 2018, Taylor & Francis
  • DOI: 10.1080/00325481.2019.1549459

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1080/00325481.2019.1549459

The following have contributed to this page: Michael S. Kelly and Dr Ashley M Huntsberry